Lynne Krummen
Corporate Officer/Principal at VIR BIOTECHNOLOGY, INC.
Profile
Lynne Krummen is currently working as the Executive VP-Product Development at Vir Biotechnology, Inc. She started this position in 2023.
Prior to her current role, she worked at Genentech, Inc. as the VP & Global Head-Biologics, Regulatory CMC from 2011 to 2018.
Dr. Krummen holds a doctorate degree from The University of Cincinnati College of Medicine.
Lynne Krummen active positions
| Companies | Position | Start |
|---|---|---|
| VIR BIOTECHNOLOGY, INC. | Corporate Officer/Principal | 2023-09-30 |
Former positions of Lynne Krummen
| Companies | Position | End |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Training of Lynne Krummen
| The University of Cincinnati College of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| VIR BIOTECHNOLOGY, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Lynne Krummen
